Alexander Vaiserman
Alexander Vaiserman
Head of the Laboratory of Epigenetics, Institute of Gerontology, Kiev, Ukraine
Verified email at geront.kiev.ua
Title
Cited by
Cited by
Year
Association between body mass index and Firmicutes/Bacteroidetes ratio in an adult Ukrainian population
A Koliada, G Syzenko, V Moseiko, L Budovska, K Puchkov, V Perederiy, ...
BMC microbiology 17 (1), 120, 2017
3672017
Gut microbiota: A player in aging and a target for anti-aging intervention
AM Vaiserman, AK Koliada, F Marotta
Ageing research reviews 35, 36-45, 2017
1692017
Epigenetic programming by early‐life stress: Evidence from human populations
AM Vaiserman
Developmental Dynamics 244 (3), 254-265, 2015
1192015
Radiation hormesis: historical perspective and implications for low-dose cancer risk assessment
AM Vaiserman
Dose-Response 8 (2), dose-response. 09-037. Vaiserman, 2010
1162010
Association between type 2 diabetes and prenatal exposure to the Ukraine famine of 1932–33: a retrospective cohort study
LH Lumey, MD Khalangot, AM Vaiserman
The lancet Diabetes & endocrinology 3 (10), 787-794, 2015
1072015
Early-life exposure to endocrine disrupting chemicals and later-life health outcomes: an epigenetic bridge?
A Vaiserman
Aging and disease 5 (6), 419, 2014
972014
Anti-aging pharmacology: promises and pitfalls
AM Vaiserman, V Lushchak, AK Koliada
Ageing research reviews 31, 9-35, 2016
822016
Hormesis and epigenetics: is there a link?
AM Vaiserman
Ageing research reviews 10 (4), 413-421, 2011
812011
Early-life nutritional programming of longevity
AM Vaiserman
Journal of developmental origins of health and disease 5 (5), 325-338, 2014
772014
Epidemiologic evidence for association between adverse environmental exposures in early life and epigenetic variation: a potential link to disease susceptibility?
A Vaiserman
Clinical epigenetics 7 (1), 96, 2015
712015
Seasonality of birth in children and young adults (0–29 years) with type 1 diabetes in Ukraine
AM Vaiserman, B Carstensen, VP Voitenko, MD Tronko, VI Kravchenko, ...
Diabetologia 50 (1), 32-35, 2007
712007
Hormesis, adaptive epigenetic reorganization, and implications for human health and longevity
AM Vaiserman
Dose-Response 8 (1), dose-response. 09-014. Vaiserman, 2010
662010
Health impacts of low-dose ionizing radiation: current scientific debates and regulatory issues
A Vaiserman, A Koliada, O Zabuga, Y Socol
Dose-Response 16 (3), 1559325818796331, 2018
562018
Metformin as a geroprotector: experimental and clinical evidence
V Piskovatska, N Stefanyshyn, KB Storey, AM Vaiserman, O Lushchak
Biogerontology 20 (1), 33-48, 2019
482019
Implementation of longevity-promoting supplements and medications in public health practice: achievements, challenges and future perspectives
A Vaiserman, O Lushchak
Journal of Translational Medicine 15 (1), 1-9, 2017
482017
HDAC inhibitors: A new promising drug class in anti-aging research
EG Pasyukova, AM Vaiserman
Mechanisms of ageing and development 166, 6-15, 2017
482017
Epigenetic drugs: a novel anti-aging strategy?
A Vaiserman, EG Pasyukova
Frontiers in genetics 3, 224, 2012
432012
Early-life origin of adult disease: evidence from natural experiments
A Vaiserman
Experimental gerontology 46 (2-3), 189-192, 2011
432011
The role of the TOR pathway in mediating the link between nutrition and longevity
O Lushchak, O Strilbytska, V Piskovatska, KB Storey, A Koliada, ...
Mechanisms of ageing and development 164, 127-138, 2017
422017
Fucoxanthin and lipid metabolism: A minireview
K Muradian, A Vaiserman, KJ Min, VE Fraifeld
Nutrition, Metabolism and Cardiovascular Diseases 25 (10), 891-897, 2015
422015
The system can't perform the operation now. Try again later.
Articles 1–20